Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia

Wing H Tong^{1

2}, Bart J Mertens³, Jan T de Faber⁴

Affiliations

¹ Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, The Netherlands.
² Argos Zorggroep "DrieMaasStede", Center for Specialized Geriatric Care, Schiedam, The Netherlands.
³ Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
⁴ The Rotterdam Eye Hospital Rotterdam, Rotterdam, The Netherlands.

Comment

Wing H Tong et al. Pediatr Blood Cancer. 2022 Nov.

. 2022 Nov;69(11):e29700.

doi: 10.1002/pbc.29700. Epub 2022 Apr 11.

Wing H Tong^{1

2}, Bart J Mertens³, Jan T de Faber⁴

¹ Department of Public Health and Primary Care (PHEG), Leiden University Medical Center, Leiden, The Netherlands.
² Argos Zorggroep "DrieMaasStede", Center for Specialized Geriatric Care, Schiedam, The Netherlands.
³ Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
⁴ The Rotterdam Eye Hospital Rotterdam, Rotterdam, The Netherlands.

No abstract available

Comment on

Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
Gotti G, Stevenson K, Kay-Green S, Blonquist TM, Mantagos JS, Silverman LB, Place AE. Gotti G, et al. Pediatr Blood Cancer. 2022 Apr;69(4):e29542. doi: 10.1002/pbc.29542. Epub 2022 Jan 6. Pediatr Blood Cancer. 2022. PMID: 35187841